These modifications reshape the interactome of FOXA1 to promote breast cancer metastasis by relocating it onto the chromatin loci of adhesion-related genes and simultaneously recruiting methyl-CpG binding protein 2 (MeCP2) to suppress the transcription of these genes (76). This evidence concerns the gene MECP2 and breast cancer.